Please login to the form below

Not currently logged in
Email:
Password:

BIA elects six new board members

Biotech trade body adds representatives from MedImmune, J&J and more

BIA J and J Patrick VerheyenUK trade body the BioIndustry Association (BIA) has elected six new members to its board.

They comprise senior figures from different member companies of the organisation, which represents the biotech industry in the UK.

The list of new members includes Patrick Verheyen (pictured right), head of Johnson & Johnson's innovation centre in London; Jane Osbourn of AstraZeneca subsidiary MedImmune; and Kevin Cox, CEO of imaging firm Imanova.

The remaining new appointments are Stephen Taylor of Fujifilm Diosynth Biotechnologies; Donna Hackett, director of life sciences consultancy firm KDH BioManagement; and Tim Watts, chief financial officer of Oxford BioMedica.

They will all serve from January 1, 2014, for term of three years.

The BIA also announced several returning board members, including John Brown of Vectura Group and Ian Tomlinson, senior VP of worldwide business development and biopharma research at GlaxoSmithKline.

“The appointees are recognised leaders of our industry and I look forward to working with them to help the BIA meet the needs of the bioscience sector in Europe's strongest bioscience cluster,” said Edward Hodgkin, BIA chairman.

15th October 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....